Vitamin D Deficiency
Conditions
Brief summary
The efficiency of different vitamin D formulations in treating suboptimal vitamin D status in adult population will be determined. It will provide insights into the influence of formulation on vitamin D absorption. A randomised controlled intervention trial will be conducted on at least 72 subjects (18-65 years) with suboptimal Vitamin D status. Subjects will be selected from a pool of subjects in Part 1 of the study, after completion of winter sampling. Study subjects will be randomised into four study groups (at least 18 subjects per study group). Three different treatments will be compared with a control group, which will not receive any supplemental Vitamin D. The three tested Vitamin D preparations in the treatment groups will be (A) oil-based VALENS vitamin D; (B) water-based VALENS vitamin D; and (C) Vitamin D capsules with starch-adsorbed vitamin D (powder). All these products are commercially available. Prior to study, actual level of vitamin D will be determined using appropriate analytical method. The treatment will be with 1000 IU Vitamin D per day, for two months, in all three groups. Second serum vitamin D level will be determined on last day of the treatment, and compared with pre-treatment vitamin D level.
Interventions
Participants will receive oil-based VALENS vitamin D, 1000 IU/day for 8 weeks.
Participants will receive water-based VALENS vitamin D, 1000 IU/day for 8 weeks.
Participants will receive vitamin D capsules with starch-adsorbed vitamin D (powder), 1000 IU/day for 8 weeks.
Sponsors
Study design
Eligibility
Inclusion criteria
* vitamin D suboptimal status * Signed Informed consent form (ICF), * Caucasian race * Age between 18 and 65 years at the time of the signature of Informed consent form (ICF), * Willingness to avoid a consumption of any food supplements containing Vitamin D during the study, except the ones prescribed by the study researchers, and to avoid use of solarium or other artificial UVB sources * Willingness to follow all study procedures
Exclusion criteria
* Pregnancy or breastfeeding, * Known or suspected allergy to any ingredient of the tested products in Part 2, * Pronounced avoidance of sunshine (eg reporting of allergy to the sun) * Use of food supplements containing Vitamin D or fish oil or omega 3 fatty acids in last three months prior to inclusion, * Special dietary habits used by a small part of the population (veganism, low-carb high-fat (LCHF) diet, caloric restriction diet, note: vegetarians are not excluded) * Diets prescribed by the medical profession * Disorders of the kidneys, thyroid, digestive tract, osteoporosis and other bone diseases, skin diseases * Other diseases and conditions that affect the absorption and synthesis of vitamin D * Exposure to stronger sunlight in the last three months prior to engaging in a survey (travel to countries with stronger sunshine, use of solarium), * The consumption of margarine or plant substitutes for milk / milk products several times a day, as these foods are most often enriched with vitamin D, * Visiting the solarium in the last three months before joining the survey, * Mental incapacity that precludes adequate understanding or cooperation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in vitamin D serum concentration after 8 weeks of supplementation | 8 weeks |
Countries
Slovenia